ADMA Biologics
ADMA
ADMA
72 hedge funds and large institutions have $165M invested in ADMA Biologics in 2019 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 38 increasing their positions, 10 reducing their positions, and 6 closing their positions.
Holders
72
Holders Change
+5
Holders Change %
+7.46%
% of All Funds
1.58%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
12
Increased
38
Reduced
10
Closed
6
Calls
$495K
Puts
$230K
Net Calls
+$265K
Net Calls Change
+$90K
Top Buyers
| 1 |
1
BlackRock
New York
|
$14M |
| 2 |
2
Millennium Management
New York
|
$3.84M |
| 3 |
3
Barclays
London,
United Kingdom
|
$1.91M |
| 4 |
PM
4
Prosight Management
Dallas,
Texas
|
$2.44M |
| 5 |
5
Northern Trust
Chicago,
Illinois
|
$2.83M |
Top Sellers
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
USAA
76
United Services Automobile Association
San Antonio,
Texas
| – | – | -11,101 | Closed |
|
|
PCP
77
Proficio Capital Partners
Newton,
Massachusetts
| – | – | -236 | Closed |
|
78
Simplex Trading
Chicago,
Illinois
| – | – | – | – |
|
|
CFGS
79
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|
|
AAM
80
Advisors Asset Management
Monument,
Colorado
| – | – | – | – |
|
|
NCM
81
Next Capital Management
New York
| $0 | 79 | +79 | New |
|